AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05697679 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Contral group
Description: One or two times each week, participants in the control group will get general lifestyle advice through SMS. They will not participate in the intervention's fitness routines, online classes, group chats, or films with health educators. Individual workout regimens, goals, or comments are not given by researchers. Participants in the control group's complaints or questions will always be answered with basic health information and suggestions. Researchers won't ask for individual advice or comments from other professionals.
Study NCT05701163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abstinence followed by semen sample collection.
Description: Abstinence is the intervention. Semen samples will be collected after abstinence periods.
Study NCT06672796 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching exercise
Description: Toe stretching
Study NCT06672796 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercise
Description: Toe stretching
Study NCT06672848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Numeretic rating scale (NRS)
Description: NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.
Study NCT06672848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Brief Pain Inventory (BPI)
Description: BPI is a chronic pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.
Study NCT06672848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: The S-LANSS Pain Score
Description: The Leeds assessment of neuropathic symptoms and signs (LANSS) Pain Scale is based on analysis of sensory description and bedside examination of sensory dysfunction, and provides immediate information in clinical settings. It was developed in two populations of chronic pain patients.
Study NCT00990301 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moexipril HCl/ Hydrochlorothiazide 15mg/ 25mg Tablet, Paddock Laboratories, Inc.
Description: test drug
Study NCT00990301 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moexipril HCl/ Hydrochlorothiazide 15mg/ 25mg Tablet, Paddock Laboratories, Inc.
Description: test drug
Study NCT04561388 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Electrocochleography
Description: Electrocochleographic responses will be evoked using different pure tone sounds delivered through an insert placed in the external auditory duct. The responses will be recorded with the electrodes of the cochlear implant connected to a dedicated interface.~Electrocochleographic responses will be collected continuously during the electrode-array insertion at the implantation surgery using 500Hz pure tone and after suturing with 250, 500, 750 and 1000Hz pure tones. Then, electrocochleographic responses to pure tones from 125 to 8000HZ (according to the subject residual hearing) will be recorded 2 weeks, 1 month, 2 months and 4 months after implantation.
Study NCT00990301 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Uniretic® 15mg/25mg Tablets
Description: reference drug
Study NCT05641077 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Visit
Description: Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via a virtual visit using videoconference technology at 6 weeks after the anticipated date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
Study NCT05641077 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Office Visit
Description: Patients randomized to this arm will be scheduled for and follow up with the surgeon or an advanced practice provider via an in-office visit at 6 weeks after the planned date of surgery. If the surgery were to be rescheduled to a future date, the postoperative visit will be moved accordingly to ensure follow-up occurs at the 6-week postoperative period.
Study NCT04561388 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pure Tone Audiometry
Description: The perception thresholds to 125, 250, 500, 750, 1000, 2000, 4000 and 8000 Hz pure tones will be measured within the month preceding the implantation using the same insert t.~Pure tone audiometry with the same frequencies will be done 2 weeks, 1, 2 and 4 months after the implantation.
Study NCT04561388 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Speech audiometry
Description: The speech perception will be assessed in silence and in noise in free field 1 and 4 months after implantation. The speech perception in silence will be assessed using monosyllabic words 60 dB SPL. Speech in noise will be assessed using an adaptative test with fixed noise level (60 dB SPL).
Study NCT06673433 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: obesity
Description: Patients diagnosed with obesity (BMI ≥ 28kg/m2)
Study NCT06673433 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: health
Description: the health control group include paticipants with nomal BMI
Study NCT06672263 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3911 tablets
Description: TQB3911 is a small molecule BCR::ABL1 allosteric inhibitor. By occupying the myristyl binding site, TQB3911 recovers the inhibition of BCR::ABL1 fusion protein kinase activity, and ultimately inhibits the proliferation of tumor cells.
Study NCT06672432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CareMom (a mobile app-based 8-wekk cognitive behavioral therapy program)
Description: The intervention is divided into daily tasks spread across eight weeks, with each day involving a variety of interactive elements such as videos, text-based content, guided reflections, and mental health check-ins. If the user misses a daily challenge, she can complete that challenge in the later days. Each week has a distinct focus that progressively builds the user's skills and understanding in managing emotional health. Tasks are designed to be short yet impactful, aiming to enhance engagement and adherence.
Study NCT06672432 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Matched Attention Control (a mobile app-based 8-week online relaxation training program)
Description: This program is designed to mirror the structure and engagement level of the intervention group, providing participants with a similar amount of interaction and daily activities. Each day, participants in the control group will complete 1-2 daily tasks focused on relaxation techniques, such as breathing exercises, mindfulness meditation, and guided imagery. Each task is brief, approximately 3 minutes in duration, making it easy for participants to incorporate into their daily routine.
Study NCT06672887 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MiLES
Description: The MiLES intervention is an open access website, accessible via an URL, but not traceable through any online search engine during the study period. Tailored for specific preferences and needs of different employees with cancer, the MiLES intervention consists of interactive videos, conversation checklists, tips and information regarding RTW guidance of employees with cancer, and an overview of involved stakeholders and relevant legislation. The MiLES intervention intends to optimize the RTW support the employer provides to the employee with cancer by enhancing the willingness and ability to implement the employer actions. The MiLES intervention focuses for example on fostering effective communication between the employer and employee, while disregarding assumptions based on previous experiences.
Study NCT05740007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IW-3300 rectal foam
Description: IW-3300 rectal foam administered daily for 12 weeks
Study NCT05740007 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo rectal foam administered daily for 12 weeks
Study NCT05115461 — intervention group
Intervention type: DEVICE
Intervention: Biodex Balance System™ SD
Description: Postural stability index values (anteroposterior, mediolateral and overall) will be measured for static and dynamic conditions.
Study NCT05062564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LipiFlow Thermal pulsation system
Description: Single treatment with LipiFlow thermal pulsation system on the eyelids within two months before surgery
Study NCT05062564 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eyelid warm compresses plus massages
Description: Eyelid warm compresses plus massages twice a day for the preoperative month
Study NCT05115461 — intervention group
Intervention type: OTHER
Intervention: questionnaires and inventories
Description: questionnaires and inventories related to primary end secondary outcomes will be applied and physical examination will be performed.
Study NCT06080347 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anti-inflammatory Diet
Description: Dietary intervention
Study NCT06080347 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy Diet
Description: Dietary intervention
Study NCT06673108 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SoLa Pelvic Therapy
Description: SoLa Pelvic Therapy laser emits near-infrared (810-980 nm wavelength) energy to the vaginal tissues. The device treats at 5-8 W for 3-6 minutes and delivers a fluence of 3,000 and 5,000 J/cm2 through a sterile vaginal probe. Specific treatment time is calculated based on vaginal length. Based on a code input, the device can cycle between emitting laser energy or sham which is visible light without focused laser energy.
Study NCT06673108 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SoLa Pelvic Therapy
Description: SoLa Pelvic Therapy laser emits near-infrared (810-980 nm wavelength) energy to the vaginal tissues. The device treats at 5-8 W for 3-6 minutes and delivers a fluence of 3,000 and 5,000 J/cm2 through a sterile vaginal probe. Specific treatment time is calculated based on vaginal length. Based on a code input, the device can cycle between emitting laser energy or sham which is visible light without focused laser energy.
Study NCT06672692 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: LIAISON NES FLU A/B, RSV & COVID-19
Description: The LIAISON® NES FLU A/B, RSV \& COVID-19 assay used on the LIAISON® NES instrument is a real-time PCR system that enables the direct amplification, detection and differentiation of Flu A viral RNA, Flu B viral RNA RSV viral RNA, and SARS-CoV-2 RNA from dry nasal swabs. Nasal Swabs can be professionally collected by a Healthcare Provider or self-collected by the patient under the supervision of the healthcare provider. The collected nasal swab can then be directly loaded into the cartridge without nucleic acid extraction.
Study NCT06672744 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Lumbar muscles (especially quadratus lumborum) and thoracolumbar fascia stretching exercises and strengthening exercises for the lumbar and abdominal muscles were described by the physiotherapist. Participants were asked to perform the exercises three times a day, five days a week
Study NCT06672744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release technique
Description: Myofascial release technique was applied by the same researcher (YY) twice a week for four weeks.
Study NCT06672744 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: Kinesiotaping was performed by the same researcher (XX) for two sessions per week for four weeks with fascia correction technique
Study NCT06672757 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CV_AID
Description: Upon arrival at the scene, the paramedic utilizes a mobile app with an integrated camera to aid in conducting the National Institutes of Health Stroke Scale (NIHSS) assessment. The app assists in scoring the patient\&#39;s responses according to NIHSS criteria to determine the severity of stroke symptoms.~If the app assessment indicates a high likelihood of stroke, transport can be initiated without a conference with the neurovascular centre. The app shares the recorded NIHSS assessment and video of the patient with the neurovascular centre for review.~While en route, the paramedic confer with the neurovascular centre to discuss the patient\&#39;s condition and determine appropriate course of action. If the neurovascular centre decides not to treat the patient, transport can be diverted to the nearest hospital.~The paramedic documents all assessment findings, interventions, and communications related to the stroke patient in the patient care record. U
Study NCT05950048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The web-based breastfeeding counseling
Description: To the web-based breastfeeding counseling/experimental group (n =33), during the first 6 months after birth, they will be directed to the web-based breastfeeding consultancy website. On this page, mothers will receive counseling on breastfeeding (written, visual, audio materials and telephone counseling) from birth. In addition, the Web-based breastfeeding counseling/experimental group will fill out data collection forms in the first 24 hours, 1st, 2nd, 4th and 6th months after delivery.
Study NCT05898646 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: X-Ray Imaging
Description: Undergo x-ray imaging
Study NCT06619990 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: XmAb942
Description: Antibody
Study NCT05898646 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05898646 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06249113 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NaCl 0.9%
Description: NaCl 0.9% continous intravenous on tumor craniotomy surgery
Study NCT06249113 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant lidocaine continous
Description: Adjuvant lidocaine continous intravenous on tumor craniotomy surgery
Study NCT06002074 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management and Resilience Training Program
Description: One-on-one stress management and resilience consultation by a certified SMART trainer followed by self-guided on-line training consisting of 4 modules.
Study NCT05350085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam besylate
Description: ① initial dose: use a micro injection pump to pump remimazolam at the rate of 50mg/h, and observe for 4 \~ 8 minutes until Ramsay Sedation grade III，then start dental operation ; ② Maintenance dose: maintain the pump speed at 5 \~ 10mg/h，adjust the pump dose to maintain the patient at Ramsay Sedation grade III. ③ Additional dose: During the operation, if the patient has body movement reaction or cannot cooperate with the dentist, local anesthetics shall be given as remedy. ④ After the operation, stop the microinjection pump.
Study NCT05350085 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: ① initial dose: use a micro injection pump to pump remazolam at the rate of 30mg/h, and observe for 4 \~ 8 minutes until Ramsay Sedation grade III，then start dental operation; ② Maintenance dose: maintain the pump speed at 3 \~ 6mg/h，adjust the pump dose to maintain the patient at Ramsay Sedation grade III. ③ Additional dose: During the operation, if the patient has body movement reaction or cannot cooperate with the dentist, local anesthetics shall be given as remedy. ④ After the operation, stop the microinjection pump.
Study NCT06619990 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06673173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Implant
Description: A long cone paralleling approach with a specially made film holder will be used to assess each patient's vertical marginal bone loss to ensure standardized radiography analysis and avoid any magnification errors. The linear distance between the proximal crestal bone level and the implant shoulder will be measured at the mesial and distal aspects of the implant measured in millimeters (mm). Measurements will performed using image measurement software patient satisfaction comparison between 2 groups
Study NCT04484441 — intervention group
Intervention type: OTHER
Intervention: Blood and placenta specimen collection.
Description: Collection of maternal and paternal blood. Collection of infant cord blood and placenta.
Study NCT05570539 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BLU-5937 IR
Description: Each subject will receive two single and multiple administrations of Immediate Release reference formulation
Study NCT05570539 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLU-5937 ER
Description: Each subject will receive single and multiple oral administrations of Extended Release formulation
Study NCT04114890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir Disoproxil Fumarate
Description: Tenofovir Disoproxil Fumarate 300 mg once daily and will continue until one month after delivery
Study NCT04310345 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Animal-Assisted Interactions
Description: Child and caregivers will spend approximately 10-5 minutes with a registered canine and its owner during potentially anxiety-producing visits to the clinic or hospital.
Study NCT04738864 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ultrasound
Description: extracranial and intracranial ultrasound assessment
Study NCT04857138 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7300490
Description: Participants will receive RO7300490, as described in the Arm Descriptions.
Study NCT04857138 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Participants will receive Atezolizumab, as described in the Arm Descriptions.
Study NCT06063460 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Periodontal examination
Description: Periodontal Examination Routine In routine periodontal examination, measurements of plaque score, gingival score, pocket depths, and attachment loss will be utilized.
Study NCT06063460 — intervention group
Intervention type: OTHER
Intervention: baseline questionnaire about sociodemographic characteristics, smoking habits, oral hygiene habits, halitosis, smell and taste perception
Description: Each patient participating in the study will complete a questionnaire detailing their age, gender, height, weight, smoking status, frequency of dental brushing, diabetes status, total annual household income, and Covid-19 history. In addition, a visual analogue scale and self-reported periodontal status questionnaire will be completed.~Personal Periodontal Condition Questionnaire This questionnaire comprises of eight questions regarding the participants' periodontal condition.~Graphical Analog Scale Patients were asked to rate their perception of taste, smell, and bad breath between 0 and 100 on this scale. Sense of smell (0-I cannot smell at all, 100-I can smell perfectly), sense of taste (0-I cannot taste at all, 100-I can smell perfectly), mouth. The odor will be graded from 0 (no bad breath) to 100 (extremely awful breath).
Study NCT06063460 — intervention group
Intervention type: OTHER
Intervention: phase I periodontal treatment
Description: Phase I periodontal treatment will be applied by same expert.
Study NCT06063460 — intervention group
Intervention type: OTHER
Intervention: 1. month periodontal evaluation and repeat questionnaire
Description: Periodontal examination will be performed in the 1st month, filling the questionnaire about halitosis, smell and taste perception.
Study NCT06063460 — intervention group
Intervention type: OTHER
Intervention: 3. month periodontal evaluation and repeat questionnaire
Description: Periodontal examination will be performed in the 3rd month, filling the questionnaire about halitosis, smell and taste perception.
Study NCT05597228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Stress Management and Health Education
Description: Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.
Study NCT05404789 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Centrifugation
Description: Subjects will participate in up to seven different centrifuge profiles over a single day of training (approximately 8 hours). Exposures are design to simulate a spaceflight profile using acceleration anticipated for commercial spaceflights.
Study NCT05918302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-edotreotide
Description: 6 cycles of 7.5 ± 0.7 Giga becquerel (GBq) 177Lu-edotreotide
Study NCT05918302 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Everolimus
Description: 10 mg orally once daily (QD)
Study NCT05116189 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV infusion
Study NCT05116189 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion
Study NCT05116189 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel
Description: IV infusion
Study NCT06530849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GC012F Injection
Description: GC012F Injection is an autologous chimeric antigen receptor T cell therapy targeting both BCMA and CD19
Study NCT04908137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate
Description: Topical Skin Adhesive is a sterile, liquid topical skin adhesive containing a monomeric (2-octyl cyanoacrylate) formulation and the colorant D \& C Violet No. 2. It is provided as a single use applicator in a blister package
Study NCT05116189 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: IV infusion